Pfizer Not Done With Deals Even After Hospira Purchase

... $66 billion purchase of Botox-maker Allergan Inc., could fulfill Pfizer's remaining needs, according to Kevin Kedra, a Rye, New York-based analyst at Gabelli & Co. The company could also look to further bolster its oncology and vaccine offerings, ...

http://ift.tt/1LTLXDZ